https://www.selleckchem.com/pr....oducts/bobcat339.htm
With pediatric-inspired chemotherapy, the survival of adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL) has improved. For standard-risk patients in the first complete remission (CR1), pediatric-inspired chemotherapy may be superior than allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, increased dose of steroid, vincristine, and L-asparaginase (L-Asp) in pediatric-inspired chemotherapy induces adverse events in certain number of adult ALL patients. Especially, the administra
Like
Comment
Share
